ProcureCon Pharma US 2018

October 22 - 23, 2018

The Westin Princeton at Forrestal Village, NJ

Contact Us: 1.888.482.6012

Day One: Monday, October 22 | The Role of Procurement in Enabling Digital Transformation

7:20 am - 8:20 am Registration and Breakfast

8:20 am - 8:30 am Welcome

8:30 am - 8:40 am Chairman’s Opening Remarks

Brian Bonnell - Vice President, Strategic Partnerships Scientist.com
An Executive from Scientist.com
img

Brian Bonnell

Vice President, Strategic Partnerships
Scientist.com

8:40 am - 9:10 am Keynote Presentation | What Will Procurement In The Global Pharma Sector Look Like In 2025?

Sanjeev Majoo - Vice President, Global Procurement - Commercial and International Bristol-Myers Squibb
Drawing on extensive experience leading global procurement organizations in diverse industries, Sanjeev Majoo, BMS’ head of international procurement, will share lessons learned transforming old to new, traditional to modern and manual to automated to offer a compelling vision of the future of Pharma procurement.

  • How has procurement evolved and what can this tell us about the future sourcing of clinical innovation?
  • How has Pharma moved on from the disruption caused by Generics companies and high intensity M&A over the past 5 years?
  • How will Brexit and Trump’s administrative changes affect you directly?
  • 5 key responsibilities for procurement to sustain the reputation of your business
  • What kind of skills should you start to develop today that will be required in the future?
  • Greater automation of procurement processes: opportunity or threat?
  • How to fully integrate procurement in the business against a backdrop of constant internal change

img

Sanjeev Majoo

Vice President, Global Procurement - Commercial and International
Bristol-Myers Squibb

As you increase investment in robotics, artificial intelligence and machine learning, how can you be sure that greater automation will lead to more efficiency? If you still have doubts, make sure you voice them during this interactive discussion with a panel of experts.

  • How is automation disrupting procurement roles today?
  • 5 major efficiency gains and losses as a result of newly automated processes
  • How to adapt your existing procurement model to take full advantage of automation
  • What will Pharma procurement teams look like in 5 years’ time?

img

Connie Walters

Executive Director, Global Procurement Commercial Strategy
Bristol-Myers Squibb

img

Adam Boal

Head Of Procurement, North America
AstraZeneca

img

Anca Copaescu

Chief Executive Officer
Strategikon Pharma

img

Brian Bonnell

Vice President, Strategic Partnerships
Scientist.com

9:50 am - 10:20 am Case Study | How Novo Nordisk Implemented A Risk-Based Approach Toward Its Suppliers, Goods And Services - Focusing On Requirements From GMP/GDP/Device Regulations

Mikkel Otte - Senior Sourcing Project Manager Novo Nordisk A/S
img

Mikkel Otte

Senior Sourcing Project Manager
Novo Nordisk A/S

10:20 am - 11:00 am Morning Networking and Refreshment Break in the Solutions Zone

  • Connecting the decisions we make in Preclinical Development to the effect in Clinical execution
  • Driving speed in the Discovery process to have our products reach the patient sooner

img

Moushmi Culver

AVP, Global Research & Development Sourcing & Procurement
Merck

img

Gabrielle Dion

Director, Central Labs & Clinical Specialty Services
Merck

img

James Wheeler

Executive Director, Research and Development Sourcing and Procurement
Merck

11:30 am - 11:50 am Presentation | Simplifying Access To Real World Evidence With An Online Platform

Julie Carter - Director, HEOR & RWE Scientist.com
Currently, Real World Evidence (RWE) refers to studies utilizing data obtained from “real world settings;” thus, it resides outside the tight controls of a clinical trial design.  The concept of RWE is not new, but the buzz surrounding RWE and the emphasis for providing such data is, and demand continues to grow.  What this means is that the field is constantly evolving, as are the ways to utilize such data to draw the best insight and value story of products.  The opportunities in this area are vast, but RWE is not without challenges.  There is still no standard process, it is difficult to access and identify the appropriate data sources and evaluating products in clinical practice is complex and time-consuming.  The most successful outcomes will result from leveraging external partnerships to navigate a difficult market as well as the best data approach.  Find out how some of the world’s largest pharmaceutical companies and most innovative biotechs are streamlining the way they identify, qualify and engage with CROs to ensure speed and proper data insight.
img

Julie Carter

Director, HEOR & RWE
Scientist.com

11:50 am - 12:20 pm Category Management In Clinical Development – How To Determine The Best Outsourcing Approach For Your Organization

Reb Tayyabkhan - Executive Director, Clinical Outsourcing Regeneron Pharmaceuticals Inc.
  • Rank and valuate key outsourcing variables  — the money, the contract and the people
  • Understanding the perspective of legal, compliance and R&D before conducting research on perspective suppliers  and analyze criteria and considerations for vetting CROs and CMOs
  • Reviewing potential vendors, requesting proposals (what info should be included)
  • Writing up outsourcing specific contracts and coming up with long term KPIs to evaluate vendors you choose to work with
  • What is the lifecycle of an outsourcing engagement? How does that evolve over time?
img

Reb Tayyabkhan

Executive Director, Clinical Outsourcing
Regeneron Pharmaceuticals Inc.

img

Jon Lightman

Partner, Life Science Solutions and Innovation
ISG

img

Susan Presberg

Director, Global Software Category - Global Technology Procurement
Abbott

12:40 pm - 1:40 pm Lunch For All Attendees

12:40 pm - 1:40 pm Private Lunch Hosted by Kelly OCG

Track A: R&D and Clinical Sourcing

1:40 pm - 2:20 pm Interactive Case Study | How To Build And Execute An Optimal R&D Category Management Strategy

Rich Polgar - Director, Global Procurement - R&D Bristol-Myers Squibb
This new age of technology and patient centricity is requiring a larger investment in R&D. How can procurement work with stakeholders and scientists to support the massive R&D spend?

  • Optimizing internal management and stakeholders to support R&D procurement
  • Evaluating the value proposition procurement provides through speed to market, risk mitigation and molding more effective partnering with the scientists
  • Managing the paradox between compliance, financial targets and R&D’s goals
  • Planning a comparator sourcing strategy before the clinical trial begins to better identify risks
  • Structuring efficiency in mapping product creation and supply during early preclinical stages to scale up commercially
  • Driving transformative change in pre-clinical support to deliver an efficient R&D program

Rich Polgar

Director, Global Procurement - R&D
Bristol-Myers Squibb

Track B: Sourcing Innovation For Indirect Categories
In many organizations, there is a misalignment between procurement and other business functions. A misunderstanding of category management can lead to terrible outcomes and the questioning of procurement's value. But for organizations that have created a solid category management strategy; there is no denying that the profile of procurement has been raised, as has its engagement at a more senior level. In this informative panel, learn how you can build the right strategy for your organization.

  • What does category management really mean in today’s enterprise?
  • Can you get rid of category management? How would you replace it?  What risks would that create – and would the stakeholders really buy in?
  • If you keep it: are there new ways to strengthen it, achieve significant cost savings, gain process efficiencies, and enhance productivity? 

James Nguyen

Global Head of Indirect Procurement
Zoetis Inc.

img

Brett Healy

Head of Global Indirect Procurement
Lonza

img

Steve Mifflin

Senior Category Manager
Mallinckrodt Pharmaceuticals

Tandra Davis

Board Member
ISM New York

Track C: Small Pharma/Biotech Boardroom

1:40 pm - 2:20 pm Workshop | Group Therapy For Leaders Of Small Procurement Teams

Chantal Sarmanoukian - Head of Procurement & Facilities AMAG Pharmaceuticals
Biotech and small pharma procurement teams can often feel overwhelmed in their role, especially those companies with less than 5 FTEs. This session will provide you with emotional guidance and self-care you need when managing a small team.  You’ll discuss:

  • Should the CFO and CPO be the same person? 
  • Determining the optimal business model to bring success to the sourcing function
  • Stakeholder management and business partnering
  • Approaches to prioritize your efforts and measure success
  • Tools and techniques for embracing organizational cultures not accustomed to sharing information

img

Chantal Sarmanoukian

Head of Procurement & Facilities
AMAG Pharmaceuticals

2:20 pm - 2:40 pm Innovative Supplier Relationship Management in R&D And Clinical Sourcing

Rich Brandwein - CTO PlanetConnect, Inc. Martin Leach - Vice President, R&D and Global Ops IT Alexion Pharmaceuticals
Supplier Relationship Management and Innovation are two key topics in Enterprise Procurement. We discuss trends to use your Suppliers and Employee base to bring these two together and enhance your process productivity. Learn about:

  • Finding and Tracking Bio/ Pharmaceutical Supplier Capabilities in a Rapidly Changing Environment
  • Ways to economically, efficiently and painlessly involve your Employees in the Supplier process
  • Capturing Innovation and Ideas from your current and potential Suppliers

img

Rich Brandwein

CTO
PlanetConnect, Inc.

img

Martin Leach

Vice President, R&D and Global Ops IT
Alexion Pharmaceuticals

2:40 pm - 3:20 pm Networking Break In The Solutions Zone

These interactive roundtable sessions take a deep dive into the specific areas you came to learn about. Sit and learn in an intimate format from thought leaders of procurement and services solution providers. Ask questions and engage with them to mutually understand some of the challenges you are facing and how you can mutually assist each other in accomplishing your respective goals. Don’t miss out on the discussions you want to participate in— you’ll get to select a new topic after 30 minutes!

Table 1: Mitigating 3rd Party Risk: Bringing The Outside In
Raj Joshi, Director, Strategic Sourcing & Procurement, Purdue Pharma

Table 2: How to Make Every Interaction Count with Your Most Challenging Stakeholders
Kai Ding, Indirect Sourcing Lead, Global Procurement, Alexion Pharmaceuticals, Inc.

Table 3: Best Practices in Developing and Maintaining an Effective Clinical Outsourcing Strategy
Ratan Ratnesh, Director, Clinical Outsourcing, Otsuka Pharmaceutical Development and Commercialization, Inc.

Table 4: Setting Up Better Systems Among Your Sourcing Team to Share Data and Capture Ideas

Table 5: Influencing Business Connectivity Through Digitization
Robb Siefert, Director, Value and Success Planning, Digital Transformation Organization, SAP Ariba

Table 6: In-Depth: How Novo Nordisk Implemented A Risk-Based Approach Toward Its Suppliers, Goods And Services - Focusing On Requirements From GMP/GDP/Device Regulations
Mikkel Otte, Senior Sourcing Project Manager, Novo Nordisk A/S

img

Raj Joshi

Director, Strategic Sourcing & Procurement
Purdue Pharma

img

Kai Ding

Indirect Sourcing Lead, Global Procurement
Alexion Pharmaceuticals

img

Ratan Ratnesh

Director, Clinical Outsourcing
Otsuka Pharmaceutical Development and Commercialization, Inc.

Robb Siefert

Director, Value and Success Planning - Digital Transformation Organization
SAP Ariba

img

Mikkel Otte

Senior Sourcing Project Manager
Novo Nordisk A/S

Track A: R&D and Clinical Sourcing
Could new digital capabilities help you meet heavy demands of internal change without neglecting strategic suppliers and driving them closer to competitors? Find out during this interactive discussion and put your point of view across too.

  • Procurement and supplier perspectives of what makes a successful relationship with a CRO
  • How to move your existing relationships with your CROs to the next level
  • Can digital capabilities be leveraged to maintain and improve partnerships?
  • 3 practical steps to digitizing your CRO relationships that benefit you

img

Lynn Newbould

Director, Procurement - Global Clinical Category Lead , Clinical and Medical Affairs Sourcing
Alnylam Pharmaceuticals

img

Ratan Ratnesh

Director, Clinical Outsourcing
Otsuka Pharmaceutical Development and Commercialization, Inc.

Kristen Eisenhauer

Senior Vice President, Client Services
Charles River

Track B: Sourcing Innovation For Indirect Categories
What you need to know about the risks and opportunities associated with the convergence of procurement/HR managing contingent within the pharmaceutical industry:

  • Co-employment and compliance issues, who’s responsible for violations?
  • Benchmarking labor costs to ensure you’re getting the best people, quickly, at the best cost
  • How large a role should MSPs play in your contingent labor workforce?
  • How the rise of the freelance economy factors into your contingent labor strategy
  • Developing playbooks to manage contract labor outside of the United States
  • If there’s a mandate to reduce employees, does staff augmentation really save money? 

img

Deirdre Bradstock

Senior Sourcing Manager, Professional Services & HR Categories
Zoetis Inc.

img

Megan Ksenzakovic

Director, Contingent Labor
Sanofi

Tandra Davis

Board Member
ISM New York

Small Pharma/Biotech Boardroom
Some pharma and biotechs usually have small spend in some categories, making it extremely difficult to get attention from and negotiate the best price with suppliers. This case study will explore how one company negotiated fair and balanced evaluations and contracts, along with best practices in negotiations today. Afterward, you’ll be encouraged to conceptualize your own revamped negotiation strategy

  • Determine the right balance of relationship and power - how many suppliers do you really need to retain buying power? And how low can you go without handing it all over?
  • Explore best practices for getting through to suppliers
  • Determine the outcome you need, and where you’ll be willing to compromise before negotiation begins
  • Balancing supplier market pricing power
  • Employing GPOs to receive volume pricing

img

Eric Woo

Strategic Sourcing and Alliance Management
Biogen

img

Raj Joshi

Director, Strategic Sourcing & Procurement
Purdue Pharma

5:00 pm - 5:40 pm Negotiation Master Class | The Art Of Procurement Meets Positive Disruption

Joanna Martinez - Founder Supply Chain Advisors
With examples culled from the best in the business, listen to a fresh take on how to tackle those big negotiations on your to-do list. In this informative workshop, learn to think differently, achieve a better outcome, and walk away with new ideas and approaches to add to your toolkit.

Joanna Martinez

Founder
Supply Chain Advisors

As treatments become more personalized, how can procurement partner with marketing and suppliers to deliver a fully realized commercialization program without breaking the bank? How can you create a detailed analytical approach to determining value, melding prescription data, payer data, and data from patients together to create a more complete picture of how best to commercialize a drug? This panel will discuss:

  • Understanding how your customers and patients consume information
  • Influencing diverse stakeholders in an increasingly personalized market
  • Mastering agency relationships to ensure full transparency
  • Market research, data and business intelligence
  • Collateral and print materials
  • Sourcing marketing automation software

img

Jill Rankin

Associate Director, Global Sourcing - Marketing & Sales
Boehringer Ingelheim

img

AnnMarie Moran

Procurement Lead Business Partner
Novartis

img

Kris Ungvarsky

Senior Director, Head of Procurement
Roivant Sciences, Inc.

Tandra Davis

Board Member
ISM New York

5:00 pm - 5:40 pm Case Study | Building A Strategic Sourcing Initiative From The Ground Up

Raj Joshi - Director, Strategic Sourcing & Procurement Purdue Pharma
It is important to build a strategic sourcing initiative the right way to get business stakeholders buy-in and maximize the chances of success. Using a real life example of sourcing the Warehousing & Distribution spend, this session will discuss how to successfully set up a sourcing initiative from ground up.

  • Identification of opportunity through spend and contract analysis
  • Evaluating an organization’s business needs and procurement’s positioning
  • Assembling the right team to initiate the sourcing process
  • How procurement facilitated cross-functional partnerships to help with the successful implementation of the sourcing initiative
img

Raj Joshi

Director, Strategic Sourcing & Procurement
Purdue Pharma

5:40 pm - 6:45 pm Harvest Fest Reception in the Solutions Zone Hosted by Scientist.com